Glucocorticoid-Induced Osteoporosis and its Impact on Rheumatic Diseases

This chapter discusses the issue of glucocorticoid-induced osteoporosis and its impact on people with rheumatic diseases. It highlights the risks associated with long-term use of prednisone, the importance of screening patients for osteoporosis, and the challenges in scheduling DEXA studies for patients with polymyalgia rheumatica.